- Country: Russia
- Summary: Drug: Dabigatrana Exislates in Favor of Citizens in Order to Social Support and Prevention of the Development of Cardiovascular Diseases and Cardiovation -...
- RUT Ref No: 114359723
- Deadline: 19 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 6831600.00
- Notice Type: Tender
- Document Ref. No.: 0820500000825000255
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Drug: Dabigatrana Exislat in favor of citizens in order to social support and prevent the development of cardiovascular diseases and cardiovascular complications in high-risk patients
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrug: Dabigatrana Exislates in Favor of Citizens in Order to Social Support and Prevention of the Development of Cardiovascular Diseases and Cardiovation -... - Russian Tender
The REGIONAL STATE STATE INSTITUTION "CENTER FOR STATE PROCUREMENT OF THE PRIMORSKY TERRITORY, a Government sector organization in Russia, has announced a new tender for Drug: Dabigatrana Exislates in Favor of Citizens in Order to Social Support and Prevention of the Development of Cardiovascular Diseases and Cardiovation -.... This tender is published on RussianTenders under RUT Ref No: 114359723 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-19.
The estimated tender value is 6831600.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
